🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The next Einstein, Curie, or Salk might be sitting in a lab right now, wondering if they should quit. Don’t let them. Fund science like the future depends on it…because actually it does.

DC shooter witness puts CNN in their place

Very high inter-reader variability is the achilles heel of #prostateMRI What if #prostateMRI could be like a lab test that gives a quantitative value indicating risk of #ProstateCancer? New 📜 Journal of Urology 🧵1/x Amer. Urol. Assn. European Association of Urology (EAU) UroToday.com PCF Science

Age shouldn’t exclude patients from robotic prostatectomy. Though minor complications are slightly more common with age, absolute risk remains <7%. Thanks to Gal Wald and Jim Hu at Weill Cornell Medicine for the continued collaboration! Urology Gold Journal sciencedirect.com/science/articl…

Prostate cancer can often be treated successfully, especially if identified early, Matt Cooperberg tells KRON4 News. “Prostate cancer screening is incredibly effective,” he says, "Men should absolutely get the baseline PSA test, ideally in mid-life." ucsfh.org/43ht9O6

Elinzanetant (neurokinin antagonist) decreases vasomotor sx among women on estrogen tx for breast cancer. Now will it work for #prostatecancer pts ADT? Great study #ASCO25

Good concise article on the status of Active Surveillance for Prostate Cancer. As treatment/surveillance becomes more precise, Screening becomes more palatable for Primary Care. via Matt Cooperberg #MensHealth cuaj.ca/index.php/jour…

Not that it's not worse now, but always good to know we've lived through "interesting times" before :)

Latest plans from our fearless leaders HHS.gov: • $27.5B (44%) cut to NIH (incl. the 15% indirect cap) • Reducing institutes to 8 (NCI stays, NIDDK does not) • Nearly $4B cut to CDC • $14B allocated for a new "Administration for a Healthy America" 🤦‍♂️ healthcaredive.com/news/hhs-2026-…

Just amazing to host Dave Penson as our 2025 Emil Tanagho VP UCSFUrology. Absolute tour de force review of QOL outcomes after #ProstateCancer treatment 🙏🏆